| 摘要 |
PROBLEM TO BE SOLVED: To obtain a medicine for diagnosing the contraction risk of prostatic cancer by finding a DNA methylated domain having high specificity for prostatic cancer patients and low specificity for prostatic hypertrophy patients and then measuring the methylation frequency of the DNA. SOLUTION: The subject method for determining the prostatic cancer, its risk or its early contraction comprises measuring a methylation frequency in one or more base sequences selected from base sequences represented by sequence number 1, sequence number 2, and sequence number 3 in the gene of a specimen separated from a living body, or an index value having a relative relation to the methylation frequency. The medicine for diagnosing the prostatic cancer, its risk or its early contraction contains a primer capable of examining a methylation frequency in one or more base sequences selected from base sequences represented by the sequence number 1, the sequence number 2, and the sequence number 3. COPYRIGHT: (C)2005,JPO&NCIPI
|
